DHP Korea Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 227

Employees

  • Stock Symbol
  • 131030

Stock Symbol

  • Share Price
  • $4.60
  • (As of Friday Closing)

DHP Korea General Information

Description

Optus Pharmaceutical Co Ltd is engaged in the manufacturing of finished medicaments.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 1106, 99 , No. 9 Star Valley Road
  • Seoul collar digital
  • Seoul
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Other Devices and Supplies
Stock Exchange
KRX
Corporate Office
  • 1106, 99 , No. 9 Star Valley Road
  • Seoul collar digital
  • Seoul
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DHP Korea Stock Performance

As of 14-Feb-2025, DHP Korea’s stock price is $4.60. Its current market cap is $70.3M with 15.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.60 $4.56 $3.40 - $7.53 $70.3M 15.3M 316K $0.46

DHP Korea Financials Summary

As of 30-Sep-2024, DHP Korea has a trailing 12-month revenue of $58.6M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 38,192 16,162 33,566 28,810
Revenue 58,569 55,395 45,396 50,040
EBITDA 9,631 11,500 6,947 10,533
Net Income 7,070 8,230 3,879 8,636
Total Assets 117,493 115,979 107,878 117,677
Total Debt 1,256 1,608 2,057 202
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DHP Korea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DHP Korea‘s full profile, request access.

Request a free trial

DHP Korea Patents

DHP Korea Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2613728-A1 Medicine container Inactive 01-Jun-2005
EP-1893156-A1 Medicine container Inactive 01-Jun-2005
US-20080283530-A1 Medicine container Inactive 01-Jun-2005
AU-2005332384-A1 Medicine container Inactive 01-Jun-2005 A61F9/0008

DHP Korea Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DHP Korea Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DHP Korea‘s full profile, request access.

Request a free trial

DHP Korea FAQs

  • When was DHP Korea founded?

    DHP Korea was founded in 2002.

  • Where is DHP Korea headquartered?

    DHP Korea is headquartered in Seoul, South Korea.

  • What is the size of DHP Korea?

    DHP Korea has 227 total employees.

  • What industry is DHP Korea in?

    DHP Korea’s primary industry is Pharmaceuticals.

  • Is DHP Korea a private or public company?

    DHP Korea is a Public company.

  • What is DHP Korea’s stock symbol?

    The ticker symbol for DHP Korea is 131030.

  • What is the current stock price of DHP Korea?

    As of 14-Feb-2025 the stock price of DHP Korea is $4.60.

  • What is the current market cap of DHP Korea?

    The current market capitalization of DHP Korea is $70.3M.

  • What is DHP Korea’s current revenue?

    The trailing twelve month revenue for DHP Korea is $58.6M.

  • What is DHP Korea’s annual earnings per share (EPS)?

    DHP Korea’s EPS for 12 months was $0.46.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »